Safety and costs analysis of early hospital discharge after brain tumour surgery: a pilot study

Carregando...
Imagem de Miniatura
Citações na Scopus
15
Tipo de produção
article
Data de publicação
2020
Título da Revista
ISSN da Revista
Título do Volume
Editora
BMC
Citação
BMC SURGERY, v.20, n.1, article ID 105, 10p, 2020
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Background A daily algorithm for hospital discharge (DAHD) is a key point in the concept of Enhanced Recovery After Surgery (ERAS) protocol. We aimed to evaluate the length of stay (LOS), rate of complications, and hospital costs variances after the introduction of the DAHD compared to the traditional postoperative management of brain tumour patients. Methods This is a cohort study with partial retrospective data collection. All consecutive patients who underwent brain tumour resection in 2017 were analysed. Demographics and procedure-related variables, as well as clinical outcomes, LOS and healthcare costs within 30 days after surgery were compared in patients before/pre-implementation and after/post-implementation the DAHD, which included: stable neurological examination; oral feeding without aspiration risk; pain control with oral medications; no intravenous medications. The algorithm was applied every morning and discharge was considered from day 1 after surgery if criteria was fulfilled. The primary outcome (LOS after surgery) analysis was adjusted for the preoperative performance status on a multivariable logistic regression model. Results A total of 61 patients were studied (pre-implementation 32, post-implementation 29). The baseline demographic characteristics were similar between the groups. After the DAHD implementation, LOS decreased significantly (median 5 versus 3 days; p = 0.001) and the proportion of patients who were discharged on day 1 or 2 after surgery increased (44.8% vs 3.1%; p < 0.001). Major and minor complications rates, readmission rate, and unplanned return to hospital in 30-day follow-up were comparable between the groups. There was a significant reduction in the median costs of hospitalization in DAHD group (US$2135 vs US$2765, p = 0.043), mainly due to a reduction in median ward costs (US$922 vs US$1623, p = 0.009). Conclusions Early discharge after brain tumour surgery appears to be safe and inexpensive. The LOS and hospitalization costs were reduced without increasing readmission rate or postoperative complications.
Palavras-chave
Brain tumours, Discharge, ERAS, Enhanced recovery after surgery, Postoperative length of stay
Referências
  1. Au K, 2016, J NEUROSURG, V125, P1130, DOI 10.3171/2015.11.JNS152151
  2. Boulton M, 2008, J NEUROSURG, V108, P649, DOI 10.3171/JNS/2008/108/4/0649
  3. Dasenbrock HH, 2015, NEUROSURG FOCUS, V39, DOI 10.3171/2015.10.FOCUS15386
  4. Dickinson H, 2015, J NEUROSURG, V122, P61, DOI 10.3171/2014.8.JNS1498
  5. Elsamadicy AA, 2018, J CLIN NEUROSCI, V47, P178, DOI 10.1016/j.jocn.2017.09.021
  6. ENGELMAN RM, 1994, ANN THORAC SURG, V58, P1742, DOI 10.1016/0003-4975(94)91674-8
  7. Fearon KCH, 2005, CLIN NUTR, V24, P466, DOI 10.1016/j.clnu.2005.02.002
  8. Grundy PL, 2008, BRIT J NEUROSURG, V22, P360, DOI 10.1080/02688690801961858
  9. Hanak BW, 2014, WORLD NEUROSURG, V81, P165, DOI 10.1016/j.wneu.2012.11.068
  10. Ljungqvist O, 2017, JAMA SURG, V152, P292, DOI 10.1001/jamasurg.2016.4952
  11. Ma RC, 2016, WORLD NEUROSURG, V93, P246, DOI 10.1016/j.wneu.2016.06.015
  12. Marcus LP, 2014, J NEUROSURG, V120, P1201, DOI 10.3171/2014.1.JNS131264
  13. Nuno M, 2014, NEUROSURGERY, V74, P196, DOI 10.1227/NEU.0000000000000243
  14. Purzner T, 2011, NEUROSURGERY, V69, P119, DOI 10.1227/NEU.0b013e318215a270
  15. Sawaya R, 1998, NEUROSURGERY, V42, P1044, DOI 10.1097/00006123-199805000-00054
  16. Sughrue ME, 2015, WORLD NEUROSURG, V84, P505, DOI 10.1016/j.wneu.2015.04.019
  17. Tsai TC, 2013, NEW ENGL J MED, V369, P1134, DOI 10.1056/NEJMsa1303118
  18. Venkatraghavan L, 2016, CAN J ANESTH, V63, P1245, DOI 10.1007/s12630-016-0717-8
  19. Wang Y, 2019, J NEUROSURG, V130, P1680, DOI 10.3171/2018.1.JNS171552
  20. Wong JM, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.7.FOCUS12183
  21. Ziai WC, 2003, CRIT CARE MED, V31, P2782, DOI 10.1097/01.CCM.0000098860.52812.24